These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 1972755

  • 1. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL, Johnson M, Bush L, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [Abstract] [Full Text] [Related]

  • 2. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
    Westwood SC, Hanson GR.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of cocaine on methamphetamine-induced neurochemical changes: characterization of cocaine as a monoamine uptake blocker.
    Hanson GR, Matsuda LA, Gibb JW.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):507-13. PubMed ID: 2886643
    [Abstract] [Full Text] [Related]

  • 12. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y, Spangler R, Yuferov VP, Schlussmann SD, Ho A, Kreek MJ.
    Brain Res Mol Brain Res; 2004 Nov 04; 130(1-2):61-7. PubMed ID: 15519677
    [Abstract] [Full Text] [Related]

  • 13. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
    Bhat RV, Baraban JM.
    J Pharmacol Exp Ther; 1993 Oct 04; 267(1):496-505. PubMed ID: 8229780
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Sep 04; 298(3):1150-3. PubMed ID: 11504813
    [Abstract] [Full Text] [Related]

  • 16. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 04; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 17. Cocaine tolerance and cross-tolerance.
    Katz JL, Griffiths JW, Sharpe LG, De Souza EB, Witkin JM.
    J Pharmacol Exp Ther; 1993 Jan 04; 264(1):183-92. PubMed ID: 8093724
    [Abstract] [Full Text] [Related]

  • 18. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
    Thomas WL, Cooke ES, Hammer RP.
    J Pharmacol Exp Ther; 1996 Jul 04; 278(1):347-53. PubMed ID: 8764369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential regulation of neuropeptide Y systems in limbic structures of the rat.
    Midgley LP, Bush LG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1993 Nov 04; 267(2):707-13. PubMed ID: 8246145
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.